This inventor holds 2 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gmbh. Active years: 1998-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,248 
1 out of 3,025 
Years Active: 1998-2005
Title: Innovations of Carlota-Silvia Jaggle
Introduction
Carlota-Silvia Jaggle is a prominent inventor based in Darmstadt, Germany. She has made significant contributions to the field of biotechnology, particularly in tumor therapy. With a total of 2 patents, her work focuses on developing innovative solutions for cancer treatment.
Latest Patents
One of her latest patents involves immunoconjugates. This invention relates to new fusion proteins that consist of a tumor-associated targeting element, preferably a monoclonal antibody or a fragment thereof, which recognizes a molecule that is preferentially expressed on human tumor cells, such as the human epidermal growth factor receptor (EGFR). The biologically active ligand, which may be a growth and/or differentiation factor, can be delivered to specific target cells or tissues using these fusion proteins. This innovation holds promise for enhancing tumor therapy.
Another significant patent is for bispecific molecules that recognize lymphocyte antigen CD2 and tumor antigens. This invention includes novel and highly effective bispecific antibody fragments that target lymphocyte CD2 antigen and any variable tumor antigen. Additionally, it introduces two new monoclonal antibodies, AICD2.M1 and AICD2.M2. The combination of these antibodies, with at least one being a bispecific antibody fragment, can be effectively utilized in tumor therapy and diagnostics.
Career Highlights
Carlota-Silvia Jaggle has worked with notable companies in the pharmaceutical industry, including Merck Patent Gesellschaft mit beschränkter Haftung and Merck Patent GmbH. Her experience in these organizations has contributed to her expertise in patenting innovative biotechnological solutions.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as Wolfgang Strittmatter and Stefan Meuer. These partnerships have further enriched her research and development efforts in the field of biotechnology.
Conclusion
Carlota-Silvia Jaggle's contributions to tumor therapy through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to inspire future developments in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile